f) to assist with the implementation of Commonwealth Government policies and programs in cancer control g) to provide financial assistance, out of money appropriated by the Parliament, for research mentioned in paragraph (e) and for the implementation of policies and programs mentioned in paragraph (f ) h) any functions that the Minister, by writing, directs Cancer Australia to perform. Within this remit, Cancer Australia is funded by the Australian Government to deliver work in specific cancer types; priority cancer research; clinical protocol development; cancer data improvements; and a grant initiative to support people with cancer. Cancer Australia is responsible for implementation of the Australian Brain Cancer Mission, which aims to double survival rates and improve the quality of life of people living with brain cancer over the next ten years to 2027, with the longer term aim of defeating brain cancer. Cancer Australia’s total appropriation in 2018-19 is $30.971 million. Over the four years to 2021-22) of this plan, it is anticipated that the total appropriation for Cancer Australia will remain relatively stable. Australian Public Service wide initiatives require that Cancer Australia continuously consider efficiencies in how it operates. As a recognised small government agency the ongoing incorporation of efficiencies presents practical challenges. In response to these challenges, Cancer Australia has adopted continuous improvement processes and applies robust risk management processes. 4.0 Environment Cancer Australia operates in a complex and evolving environment with current and emerging challenges. Australia’s growing and ageing population will continue to future increases in cancer incidence and health service utilisation, while cancer care is becoming increasingly complex and costly, with the development of new treatments and technologies. Australia’s increasing expenditure on health highlights the importance of priority-driven investment in cancer control to guide the optimal use of available resources and enable the health system to be responsive to these and future challenges. Cancer Australia’s Corporate Plan 2018-19 has been developed within the context of this changing landscape for the reporting periods covered by this Plan (the financial years 2019-20, 2020-21 and 2021-22). Some of these specific trends and future challenges, and how Cancer Australia intends to achieve its purpose are captured below. Strategic outlook over the forward In Australia, cancer is a national health priority. In 2017, it was estimated that one in two people were at risk of being diagnosed with cancer by the age of 85 years. More people are being diagnosed with cancer and the incidence is projected to increase by 8.4 per cent to approximately 150,000, by 2020.
5.0 Performance Cancer Australia’s purpose is to minimise the impact of cancer in Australia, address disparities and improve the health outcomes of people affected by cancer in Australia. The following tables provide the outlook for each of the financial years 2018-19, 2019-20, 2020-21 and 2021-22. Cancer Australia’s performance management framework provides a means to monitor and analyse progress; ensure alignment of our efforts with our purpose; and maintain strong links between performance reporting, planning and management. It also enables measurement of our progress towards the achievement of our main activities. Outlook for 2018-19 Provide leadership in national cancer control and promote appropriate cancer care How we will do it in 2018-19 What we will achieve in 2018-19 (intended results) How we will measure our achievement in 2018-19 (annual performance targets) Develop advice on cancer control. Research is translated into evidence-based information, policy and clinical practice to support policy makers and health professionals. Through the publication of research evidence and guidance inform policy and clinical best practice. Lead a shared agenda for improvements in cancer outcomes for Aboriginal and Torres Strait Islander peoples as outlined in the National Aboriginal and Torres Strait Islander Cancer Framework. Identify and leverage opportunities in agreed priority to improve cancer outcomes for Aboriginal and Torres Strait Islander peoples. Advancement of a national dataset for reporting and monitoring on progress against the National Aboriginal and Torres Strait Islander Cancer Framework. Report and monitor trends in national cancer control indicators (NCCI). National data on cancer control is available to inform health professionals, researchers, health policy and decision makers, and the community. Report on annual of the NCCI website.
Outlook for 2018-19 continued Fund priority research and strengthen national data capacity How we will do it in 2018-19 What we will achieve in 2018-19 (intended results) How we will measure our achievement in 2018-19 (annual performance targets) Partner with organisations to maximise Government investment in cancer research through the PdCCRS. Priority cancer research is funded. Minimum number of cancer research grants funded through the Collaborative Research Scheme: 20 Establish a contestable grant program to fund brain cancer research under the Australian Brain Cancer Mission. New and expanded clinical trials and international collaborations are funded to improve outcomes and/or quality of life for Australians diagnosed with brain cancer. Up to 2 new and/or expanded clinical trials are funded. Fast-track international collaborations for paediatric brain cancer research. Funding to international collaborative clinical trials in paediatric brain cancer in Australia. Up to 2 international collaborative clinical trials in paediatric brain cancer in Australia are funded. Report on cancer stage and diagnoses on the NCCI. Report five-year survival by cancer stage for a range of cancers to inform policy and clinical decision makers. National data on five-year survival by cancer stage reported for the top 5 adult and 16 paediatric cancer types. government
Outlook for 2018-19 continued Promote cancer awareness and provide information about cancer to the community How we will do it in 2018-19 What we will achieve in 2018-19 (intended results) How we will measure our achievement in 2018-19 (annual performance targets) Promote cancer information on the Cancer Australia websites, including the Children’s Cancer website, and social media platforms. Evidence-based cancer information, resources and data is available and accessible to consumers, health professionals and the community on the Cancer Australia websites and social media platforms. Total number of Cancer Australia resources available to inform the community: 290 Regularly review and update the Cancer Australia websites and social media platforms to ensure up-to-date, evidence informed cancer information, resources and data is available. Increase number of visits to the Cancer Australia online platform by 8%. Continue to involve and engage consumers in advisory groups and project activities to inform Cancer Australia’s work. Involvement and engagement of consumers in Cancer Australia advisory groups and project activities to inform our work and be responsive to consumer need. Number of consumers involved in Cancer Australia advisory and project activities: 80 Outlook for 2019-20 How we will do it in 2019-20 What we will achieve in 2019-20 (intended results) How we will measure our achievement in 2019-20 (annual performance targets)
Provide leadership in national cancer control and promote appropriate cancer care Develop advice on cancer control. Research is translated into evidence-based information, policy and clinical practice to support policy makers and health professionals. Through the publication of research evidence and guidance inform policy and clinical best practice. Lead a shared agenda for improvements in cancer outcomes for Aboriginal and Torres Strait Islander peoples as outlined in the National Aboriginal and Torres Strait Islander Cancer Framework. Identify and leverage opportunities in agreed priority areas to improve cancer outcomes for Aboriginal and Torres Strait Islander peoples. Reporting on indicators to monitor the progress in agreed priority of the National Aboriginal and Torres Strait Islander Cancer Framework. Report and monitor trends in national cancer control indicators (NCCI). National data on cancer control is available to inform health professionals, researchers, health policy and decision makers, and the community. Report on annual of the NCCI website. Outlook for 2019-20 continued How we will do it in 2019-20 What we will achieve in 2019-20 (intended results) How we will measure our achievement in 2019-20 (annual performance targets)
Fund priority research and strengthen national data capacity Partner with organisations to maximise Government investment in cancer research through the PdCCRS. Priority cancer research is funded. Minimum number of cancer research grants funded through the Collaborative Research Scheme: 20 Establish a contestable grant program to fund brain cancer research under the Australian Brain Cancer Mission. New and expanded clinical trials and international collaborations are funded to improve outcomes and/or quality of life for Australians diagnosed with brain cancer. Up to 2 new and/or expanded clinical trials are funded. Fast-track international collaborations for paediatric brain cancer research. Funding to international collaborative clinical trials in paediatric brain cancer in Australia. Up to 2 international collaborative clinical trials in paediatric cancer in Australia are funded. Collaborate with Australian and state/territory partners to facilitate linkage of cancer data. Link population-level cancer data for the top 5 most common cancers. Data linkage to inform national cancer control interventions. government
Provide leadership in national cancer control and promote appropriate cancer care Develop advice on cancer control. Research is translated into evidence-based information, policy and clinical practice to support policy makers and health professionals. Through the publication of research evidence and guidance inform policy and clinical best practice. Lead a shared agenda for improvements in cancer outcomes for Aboriginal and Torres Strait Islander peoples as outlined in the National Aboriginal and Torres Strait Islander Cancer Framework. Identify and leverage opportunities in agreed priority areas to improve cancer outcomes for Aboriginal and Torres Strait Islander peoples. Reporting on indicators to monitor the progress in agreed priority areas of the National Aboriginal and Torres Strait Islander Cancer Framework. Report and monitor trends in national cancer control indicators (NCCI). National data on cancer control is available to inform health professionals, researchers, health policy and decision makers, and the community. Report on annual of the NCCI website. Outlook for 2020-21 continued How we will do it in 2020-21 What we will achieve in 2020-21 (intended results) How we will measure our achievement in 2020-21 (annual performance targets)
Fund priority research and strengthen national data capacity Partner with organisations to maximise Government investment in cancer research through the PdCCRS. Priority cancer research is funded. Minimum number of cancer research grants funded through the Collaborative Research Scheme: 20 Establish a contestable grant program to fund brain cancer research under the Australian Brain Cancer Mission. New and expanded clinical trials and international collaborations are funded to improve outcomes and/or quality of life for Australians diagnosed with brain cancer. Up to 2 new and/or expanded clinical trials are funded. Fast-track international collaborations for paediatric brain cancer research. Funding to international collaborative clinical trials in paediatric cancer in Australia. Up to 2 international collaborative clinical trials in paediatric brain cancer in Australia are funded. Collaborate with international, Australian and state/territory partners to develop an approach for the collection of cancer recurrence for select cancers. Validation of a methodology for standardised cancer recurrence for up to two cancer types. Methodology for standardised cancer recurrence developed. Outlook for 2020-21 continued How we will do it in 2020-21 What we will achieve in 2020-21 (intended results) How we will measure our achievement in government
Promote cancer awareness and provide information about cancer to the community 2020-21 (annual performance targets) Promote cancer information on the Cancer Australia websites, including the Children’s Cancer website, and social media platforms. Evidence-based cancer information, resources and data is available and accessible to consumers, health professionals and the community on the Cancer Australia websites and social media platforms. number of Cancer Australia resources available to inform the community: 290 Regularly review and update the Cancer Australia websites and social media platforms to ensure up-to-date, evidence informed cancer information, resources and data is available. Increase number of visits to the Cancer Australia online platform by 5%. Continue to involve and engage consumers in advisory groups and project activities to inform Cancer Australia’s work. Involvement and engagement of consumers in Cancer Australia advisory groups and project activities to inform our work and be responsive to consumer need. Number of consumers involved in Cancer Australia advisory and project activities: 80 Outlook for 2021-22 How we will do it in 2021-22 What we will achieve in 2021-22 (intended results) How we will measure our achievement in 2021-22 (annual performance targets)
Provide leadership in national cancer control and promote appropriate cancer care Develop advice on cancer control. Research is translated into information, policy and clinical practice to support policy makers and health professionals. Through the publication of research evidence and guidance inform policy and clinical best practice. Lead a shared agenda for improvements in cancer outcomes for Aboriginal and Torres Strait Islander peoples as outlined in the National Aboriginal and Torres Strait Islander Cancer Framework. Identify and leverage opportunities to improve cancer outcomes for Aboriginal and Torres Strait Islander peoples. Reporting on indicators to monitor the progress in agreed priority areas of the National Aboriginal and Torres Strait Islander Cancer Framework. Report and monitor trends in national cancer control indicators (NCCI). National data on cancer control is available to inform health professionals, researchers, health policy and decision makers, and the community. Report on annual of the NCCI website. Outlook for 2021-22 continued How we will do it in 2021-22 What we will achieve in 2021-22 (intended results) How we will measure our achievement in 2021-22 (annual performance targets)